Granules completed the acquisition of Senn Chemicals.

Granules, an Indian multinational pharmaceutical manufacturing company, completed the acquisition of Senn Chemicals, a Swiss-based CDMO specializing in peptides. Financial terms were not disclosed. "The acquisition of Senn Chemicals AG marks a significant milestone in Granules' strategic growth journey. By entering the rapidly growing peptide therapeutics segment and acquiring CDMO capabilities, we are expanding into next-generation therapeutics that align with our commitment to innovation and affordability. Senn's expertise in peptide synthesis, coupled with our large-scale, cost-efficient manufacturing capabilities, positions us to deliver high-quality peptide-based solutions globally. This acquisition is a pivotal moment in our vision to transform Granules to a science and innovation led organization and become a trusted partner in complex and specialized therapeutics," Dr. Krishna Prasad Chigurupati, Granules Chairman & Managing Director.